QUEST DIAGNOSTICS INCORPORATED

Lobbying for QUEST DIAGNOSTICS INCORPORATED

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$690,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 8

S 2355
Patients Deserve Price Tags Act
HR 5582
Patients Deserve Price Tags Act
S 1816
Improving Seniors’ Timely Access to Care Act of 2025
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025
S 2761
RESULTS Act
HR 5269
RESULTS Act
HR 5571
Expanding Seniors’ Access to PFAS Testing Act
HR 6130
ASAP Act

Lobbying activity 3

Health Issues

Federal policy related to strengthening the clinical laboratory workforce S. 2355 and H.R. 5582 - Patients Deserve Price Tags Act S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025

Budget/Appropriations

Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing

Medicare/Medicaid

S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act H.R. 6130 - Alzheimers Screening and Prevention Act of 2025 Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.